Quantcast

Latest Blood glucose monitoring Stories

2014-04-23 23:09:58

Live webinar to focus on the development of a novel telemetry device for continuous monitoring of glucose in rodents. The broadcast takes place on Tuesday, May 13, 2014 at 11:00am EDT (16:00 UK BST/ GMT +1). Toronto, Canada (PRWEB) April 23, 2014 Glucose monitoring options for preclinical research have historically been limited when compared to the options available for human monitoring. As an example, Continuous Glucose Monitors (CGMs) have been prevalent in human medical applications...

2014-04-14 12:34:30

New Abbott test could help physicians diagnose people in the U.S. who are unaware that they have diabetes, empowering them to control their disease ABBOTT PARK, Ill., April 14, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that its new ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test - which can aid physicians in diagnosing and monitoring diabetes and identifying people at risk for the disease - has received 510(k) clearance from the U.S. Food and Drug...

2014-04-14 12:32:44

Conference Call and Webcast at 8:30 a.m. Eastern Time THE WOODLANDS, Texas, April 14, 2014 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today positive, top-line results in a Phase 2 clinical trial of LX4211 in type 1 diabetes, which achieved the primary endpoint of reducing mealtime insulin use as well as several secondary endpoints, including improved glycemic control. LX4211 is an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2...

2014-04-09 08:28:28

Dario's Diabetes Management Solution Now Incorporates Regionally Localized Food Database to Better Manage Sugar Levels CAESAREA, Israel, April 9, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario(TM) Diabetes Management Solution, today announced a partnership with the world's leading global nutrition data application, FatSecret. The FatSecret platform is being integrated with Dario's powerful diabetes management software application to deliver...

2014-04-08 08:32:56

CHEYENNE, Wyo., April 8, 2014 /PRNewswire/ -- Today TecMed, Inc. announced that its optical measurement IP has set a new standard in blood glucose measurement technologies. TecMed's IP is reported to have the greatest precision in the measurement of blood glucose, and other chiral molecules, compared to other technologies currently commercially available. TecMed, Inc.'s IP could potentially replace and improve existing measurement, and light energy management, technologies across both...

2014-04-04 23:23:45

ResearchMoz.us includes new market research report "Glucose Monitoring Device Market to 2019" to its huge collection of research reports. Full report with TOC at http://www.researchmoz.us/glucose-monitoring-device-market-to-2019-technology-adoption-and-increasing-health-awareness-serve-as-distinct-regional-growth-drivers-report.html. Albany,New York (PRWEB) April 04, 2014 Researchmoz presents this most up-to-date research on "Glucose Monitoring Device Market to 2019 -...

2014-04-02 04:21:16

DUBLIN, April 2, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/ch672j/continuous) has announced the addition of the "Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) - Global Forecasts to 2020" [http://www.researchandmarkets.com/research/ch672j/continuous ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Continuous...

2014-03-31 08:29:38

SAN DIEGO, March 31, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that the primary endpoint of non-inferiority of A1C levels at six months was met for the CONSISTENT 1 trial. The trial is evaluating Hylenex(® )recombinant and a new formulation of Hylenex currently under U.S Food and Drug Administration (FDA) review, when used as pretreatment of the insulin infusion site in patients with type 1 diabetes receiving continuous subcutaneous insulin...

2014-03-26 11:16:16

A mathematical model created by Penn State researchers can predict with more than 90 percent accuracy the blood glucose levels of individuals with type 1 diabetes up to 30 minutes in advance of imminent changes in their levels -- plenty of time to take preventative action. "Many people with type 1 diabetes use continuous glucose monitors, which examine the fluid underneath the skin," said Peter Molenaar, Distinguished Professor of Human Development and Family Studies and of psychology....

2014-03-25 20:22:24

DUBLIN, March 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/2vndzv/blood_glucose) has announced the addition of the "Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast - Worldwide" [http://www.researchandmarkets.com/research/2vndzv/blood_glucose ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Blood glucose monitoring devices market...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related